282 related articles for article (PubMed ID: 32098717)
1. Effect of particle size on the cellular uptake and anti-inflammatory activity of oral nanotherapeutics.
Zhou X; Liu Y; Wang X; Li X; Xiao B
Colloids Surf B Biointerfaces; 2020 Mar; 187():110880. PubMed ID: 32098717
[TBL] [Abstract][Full Text] [Related]
2. Oral nanotherapeutics with enhanced mucus penetration and ROS-responsive drug release capacities for delivery of curcumin to colitis tissues.
Huang Y; Canup BSB; Gou S; Chen N; Dai F; Xiao B; Li C
J Mater Chem B; 2021 Feb; 9(6):1604-1615. PubMed ID: 33471012
[TBL] [Abstract][Full Text] [Related]
3. Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.
Xiao B; Xu Z; Viennois E; Zhang Y; Zhang Z; Zhang M; Han MK; Kang Y; Merlin D
Mol Ther; 2017 Jul; 25(7):1628-1640. PubMed ID: 28143741
[TBL] [Abstract][Full Text] [Related]
4. Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation.
Xiao B; Zhang Z; Viennois E; Kang Y; Zhang M; Han MK; Chen J; Merlin D
Theranostics; 2016; 6(12):2250-2266. PubMed ID: 27924161
[TBL] [Abstract][Full Text] [Related]
5. Oral Drug Delivery Systems for Ulcerative Colitis Therapy: A Comparative Study with Microparticles and Nanoparticles.
Ma P; Si X; Chen Q; Ma L; Hou M; Xu Z; Kang Y; Wang J; Xiao B
Curr Cancer Drug Targets; 2019; 19(4):304-311. PubMed ID: 30332962
[TBL] [Abstract][Full Text] [Related]
6. Oral administration of colitis tissue-accumulating porous nanoparticles for ulcerative colitis therapy.
Chen Q; Gou S; Ma P; Song H; Zhou X; Huang Y; Kwon Han M; Wan Y; Kang Y; Xiao B
Int J Pharm; 2019 Feb; 557():135-144. PubMed ID: 30594685
[TBL] [Abstract][Full Text] [Related]
7. Oral administration of chondroitin sulfate-functionalized nanoparticles for colonic macrophage-targeted drug delivery.
Zhang X; Ma Y; Ma L; Zu M; Song H; Xiao B
Carbohydr Polym; 2019 Nov; 223():115126. PubMed ID: 31426992
[TBL] [Abstract][Full Text] [Related]
8. Carboxymethyl chitosan microspheres loaded hyaluronic acid/gelatin hydrogels for controlled drug delivery and the treatment of inflammatory bowel disease.
Zhang S; Kang L; Hu S; Hu J; Fu Y; Hu Y; Yang X
Int J Biol Macromol; 2021 Jan; 167():1598-1612. PubMed ID: 33220374
[TBL] [Abstract][Full Text] [Related]
9. Multi-bioresponsive silk fibroin-based nanoparticles with on-demand cytoplasmic drug release capacity for CD44-targeted alleviation of ulcerative colitis.
Gou S; Huang Y; Wan Y; Ma Y; Zhou X; Tong X; Huang J; Kang Y; Pan G; Dai F; Xiao B
Biomaterials; 2019 Aug; 212():39-54. PubMed ID: 31103945
[TBL] [Abstract][Full Text] [Related]
10. Curcumin loaded chitosan nanoparticles impregnated into collagen-alginate scaffolds for diabetic wound healing.
Karri VV; Kuppusamy G; Talluri SV; Mannemala SS; Kollipara R; Wadhwani AD; Mulukutla S; Raju KR; Malayandi R
Int J Biol Macromol; 2016 Dec; 93(Pt B):1519-1529. PubMed ID: 27180291
[TBL] [Abstract][Full Text] [Related]
11. Lycium barbarum lipid-based edible nanoparticles protect against experimental colitis.
Zu M; Song H; Zhang J; Chen Q; Deng S; Canup BSB; Yuan Y; Xiao B
Colloids Surf B Biointerfaces; 2020 Mar; 187():110747. PubMed ID: 31924469
[TBL] [Abstract][Full Text] [Related]
12. Oral administration of pH-sensitive curcumin-loaded microparticles for ulcerative colitis therapy.
Xiao B; Si X; Zhang M; Merlin D
Colloids Surf B Biointerfaces; 2015 Nov; 135():379-385. PubMed ID: 26275840
[TBL] [Abstract][Full Text] [Related]
13. An efficient enzyme-triggered controlled release system for colon-targeted oral delivery to combat dextran sodium sulfate (DSS)-induced colitis in mice.
Li S; Jin M; Wu Y; Jung S; Li D; He N; Lee MS
Drug Deliv; 2021 Dec; 28(1):1120-1131. PubMed ID: 34121560
[TBL] [Abstract][Full Text] [Related]
14. Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel.
Sun L; Liu Z; Wang L; Cun D; Tong HHY; Yan R; Chen X; Wang R; Zheng Y
J Control Release; 2017 May; 254():44-54. PubMed ID: 28344018
[TBL] [Abstract][Full Text] [Related]
15. Urocanic acid-modified chitosan nanoparticles can confer anti-inflammatory effect by delivering CD98 siRNA to macrophages.
Xiao B; Ma P; Viennois E; Merlin D
Colloids Surf B Biointerfaces; 2016 Jul; 143():186-193. PubMed ID: 27011348
[TBL] [Abstract][Full Text] [Related]
16.
Zhang L; Yang S; Wong LR; Xie H; Ho PC
Mol Pharm; 2020 Nov; 17(11):4256-4269. PubMed ID: 33084343
[TBL] [Abstract][Full Text] [Related]
17. TNFα gene silencing mediated by orally targeted nanoparticles combined with interleukin-22 for synergistic combination therapy of ulcerative colitis.
Xiao B; Chen Q; Zhang Z; Wang L; Kang Y; Denning T; Merlin D
J Control Release; 2018 Oct; 287():235-246. PubMed ID: 30107214
[TBL] [Abstract][Full Text] [Related]
18. Chitosan/Alginate Nanoparticles for the Enhanced Oral Antithrombotic Activity of Clam Heparinoid from the Clam
Chen GL; Cai HY; Chen JP; Li R; Zhong SY; Jia XJ; Liu XF; Song BB
Mar Drugs; 2022 Feb; 20(2):. PubMed ID: 35200665
[TBL] [Abstract][Full Text] [Related]
19. Effects of mannose density on in vitro and in vivo cellular uptake and RNAi efficiency of polymeric nanoparticles.
Chu S; Tang C; Yin C
Biomaterials; 2015 Jun; 52():229-39. PubMed ID: 25818429
[TBL] [Abstract][Full Text] [Related]
20. Berberine-Loaded Nanostructured Lipid Carriers Enhance the Treatment of Ulcerative Colitis.
Deng J; Wu Z; Zhao Z; Wu C; Yuan M; Su Z; Wang Y; Wang Z
Int J Nanomedicine; 2020; 15():3937-3951. PubMed ID: 32581538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
